Stocksigma LogoStocksigma Logo

Shelter Pharma H1 FY27 Results: Revenue Up 35.6% YoY, Eyes Capacity Doubling

Shelter Pharma reported strong standalone H1 FY27 results, with revenue rising 35.6% YoY to Rs 451.3 mn and PAT increasing 15.4% YoY to Rs 51.9 mn

Shelter Pharma H1 FY27 Results: Revenue Up 35.6% YoY, Eyes Capacity Doubling

Shelter Pharma Ltd · Outcome · 07 Nov 2026, 11:06 pm

Shelter Pharma H1 FY27 Results: Revenue Up 35.6% YoY, Eyes Capacity Doubling Shelter Pharma reported strong standalone H1 FY27 results, with revenue rising 35.6% YoY to Rs 451.3 mn and PAT increasing 15.4% YoY to Rs 51.9 mn. EBITDA grew 17.9% YoY to Rs 73.8 mn, though EBITDA margins contracted 244 bps YoY to 16.4% due to elevated freight and manpower costs. The company remains virtually debt-free with net debt-to-equity at 0.03x. Management guided for 35–40% revenue growth in FY27 and plans a Rs 120–150 mn capex to double revenue capacity beyond Rs 2,000 mn by 2028.

Original exchange filing (PDF)

More announcements from Shelter Pharma Ltd

All Shelter Pharma Ltd announcements